Campus your proton
therapy community
  • Log in
Menu
  • About Campus
  • Resources
    • All resources
    • Webinars
    • Podcasts
    • User cases
    • White Papers
    • Publications
    • User meetings
  • Events
  • Forums
  • Training
  • Connect

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event (0)
  • Podcast (0)
  • Publications (5)
  • Training (0)
  • User case (0)
  • User meeting (0)
  • Webinar (0)
  • White paper (0)
Key content topics
Key audience
  • Advanced (0)
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (0)
  • Breast (0)
  • Gastro-intestinal (4)
  • Genito-urinary (0)
  • Head and neck (0)
  • Hodgkin and Non-Hodgkin lymphoma (0)
  • Ocular (0)
  • Pediatric (0)
  • Reirradiation (0)
  • Sarcomas (0)
  • Thoracic (0)
  • Reset filters
  • (-) Intrahepatic Cholangiocarcinoma

Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.

11/12/2019
/ Publications
/
Hypofractionation
Intrahepatic Cholangiocarcinoma
Liver
Gastrointestinal
Overall Survival
Gastrointestinal

This study by MGH retrospectively analyzed 66 patients with unresectable intrahepatic cholangiocarcinoma (ICC) who were treated with hypofractionated proton (32...

Proton beam therapy for liver cancers.

03/02/2020
/ Publications
/
Gastrointestinal
Liver
Hepatocellular carcinoma
PBT
Intrahepatic Cholangiocarcinoma
Dosimetry
Toxicity

A review article examined the latest utilization of PBT for hepatocellular carcinoma and cholangiocarcinoma, as well as liver metastasis. The dosimetric...

Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma.

03/03/2020
/ Publications
/
Gastrointestinal
Passive scattering
Hepatocellular carcinoma
Overall Survival
Liver
Intrahepatic Cholangiocarcinoma

A study by the Samsung group from Korea published in the Green Journal. A total of 103 patients treated with proton therapy including 70 in the PS group and 33...

Clinical results of active scanning proton therapy for primary liver tumors.

10/07/2020
/ Publications
/
Liver
Active scanning
Gastrointestinal
Intrahepatic Cholangiocarcinoma

This study reported clinical outcomes of 18 patients including 14 patients with hepatocellular carcinoma (HCC) and 3 patients with intrahepatic...

Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma.

16/01/2023
/ Publications
/
Intrahepatic Cholangiocarcinoma
Liver

Published by the group from National Cancer Center, Korea, this study reported clinical outcomes of 47 patients with intrahepatic cholangiocarcinoma (IHCC)...

Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
Footer menu
  • About Campus
  • Resources
  • Forums
  • Training
  • Connect
  • Back to IBA Proton Therapy
Life Science
Footer Bottom
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies